Apotea AB (publ)
F:V30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apotea AB (publ)
F:V30
|
SE |
|
P
|
PetroChina Co Ltd
DUS:PC6
|
CN |
|
A
|
Arrow Electronics Inc
XMUN:ARW
|
US |
|
R
|
Rathbones Group PLC
OTC:RTBBF
|
UK |
|
W
|
Weichai Power Co Ltd
XMUN:WI4
|
CN |
Wall St Price Targets
V30 Price Targets Summary
Apotea AB (publ)
According to Wall Street analysts, the average 1-year price target for V30 is 9.275 EUR with a low forecast of 7.435 EUR and a high forecast of 11.367 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V30's stock price target?
Price Target
9.275
EUR
According to Wall Street analysts, the average 1-year price target for V30 is 9.275 EUR with a low forecast of 7.435 EUR and a high forecast of 11.367 EUR.
What is the Revenue forecast for Apotea AB (publ)?
Projected CAGR
12%
Over the last 3 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Apotea AB (publ)?
Projected CAGR
22%
Over the last 3 years, the compound annual growth rate for Operating Income has been 83%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Apotea AB (publ)?
Projected CAGR
24%
Over the last 3 years, the compound annual growth rate for Net Income has been 126%. The projected CAGR for the next 3 years is 24%.
